This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week, including:
- A video interview with Dr. Mitchell Horwitz, principal investigator and professor of medicine at the Duke Cancer Institute, that discusses the results of a phase 3 study of omidubicel and were recently presented at the Transplantation & Cellular Therapy Meetings of the American Society of Transplantation and Cellular Therapy and Center for International Blood & Marrow Transplant Research meetings.
- Representatives from the Academy of Managed Care Pharmacy student chapter at Nova Southeastern University discuss the challenges of remote learning during the coronavirus disease 2019 pandemic.
- An article that examines the scale of COVID-19 vaccinations over the next several weeks and months. As millions more people become eligible for the COVID-19 vaccine, there needs to be concerted effort to leverage innovative technologies to provide better transparency, visibility, and predictability to the vaccine deployment initiatives.